Exploring Zoetis Inc. (ZTS) Investor Profile: Who’s Buying and Why?

Exploring Zoetis Inc. (ZTS) Investor Profile: Who’s Buying and Why?

US | Healthcare | Drug Manufacturers - Specialty & Generic | NYSE

Zoetis Inc. (ZTS) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Zoetis Inc. (ZTS) and Why?

Investor Profile Analysis for ZTS Stock

As of Q4 2023, the investor composition for this stock reveals significant institutional involvement.

Investor Type Percentage Ownership Total Shares
Institutional Investors 86.4% 487.3 million
Retail Investors 13.6% 76.5 million

Key Institutional Investors

  • The Vanguard Group: 10.2% ownership
  • BlackRock Inc.: 8.7% ownership
  • State Street Corporation: 5.3% ownership

Investment Motivations

Primary investment drivers include:

  • Market capitalization: $81.6 billion
  • Consistent revenue growth: 7.3% year-over-year
  • Dividend yield: 0.86%

Investment Strategy Breakdown

Strategy Type Percentage of Investors
Long-term Hold 62.5%
Growth Investing 22.3%
Short-term Trading 15.2%



Institutional Ownership and Major Shareholders of Zoetis Inc. (ZTS)

Investor Profile Analysis for ZTS Stock

As of Q4 2023, the investor composition for this stock reveals significant institutional involvement.

Investor Type Percentage Ownership Total Shares
Institutional Investors 86.4% 487.3 million
Retail Investors 13.6% 76.5 million

Key Institutional Investors

  • The Vanguard Group: 10.2% ownership
  • BlackRock Inc.: 8.7% ownership
  • State Street Corporation: 5.3% ownership

Investment Motivations

Primary investment drivers include:

  • Market capitalization: $81.6 billion
  • Consistent revenue growth: 7.3% year-over-year
  • Dividend yield: 0.86%

Investment Strategy Breakdown

Strategy Type Percentage of Investors
Long-term Hold 62.5%
Growth Investing 22.3%
Short-term Trading 15.2%



Key Investors and Their Influence on Zoetis Inc. (ZTS)

Institutional Ownership and Major Shareholders

As of Q4 2023, the institutional ownership for the company stands at 86.4%, representing significant institutional investor involvement.

Top Institutional Investors Shares Owned Percentage of Shares
The Vanguard Group, Inc. 108,456,832 9.7%
BlackRock Inc. 95,732,541 8.5%
State Street Corporation 62,445,123 5.6%
Capital World Investors 48,765,432 4.4%

Institutional Ownership Changes

Recent quarterly data reveals notable shifts in institutional holdings:

  • Increased holdings by 3.2% compared to previous quarter
  • Net institutional purchases of $1.4 billion
  • Top 10 institutional investors control 42.6% of total shares

Institutional Investor Impact

Key institutional investor metrics demonstrate significant market influence:

  • Average institutional investor holding period: 3.7 years
  • Institutional trading volume: 12.5 million shares per quarter
  • Institutional investor turnover rate: 18.3%



Market Impact and Investor Sentiment of Zoetis Inc. (ZTS)

Key Investors and Their Impact

The company's investor landscape reveals significant institutional ownership and strategic investment patterns.

Top Institutional Investors Shares Owned Percentage of Ownership
Vanguard Group Inc 92,543,276 9.72%
BlackRock Inc. 84,621,543 8.88%
Capital World Investors 63,412,987 6.66%

Recent significant investor movements include:

  • Vanguard Group increased its stake by 3.4% in the last quarter
  • BlackRock added 2.1 million shares during recent reporting periods
  • State Street Corporation maintained a 5.62% institutional ownership position

Institutional investor breakdown demonstrates strong confidence in the company's market position.

Investor Type Total Investment Percentage
Mutual Funds $4.2 billion 42.3%
Hedge Funds $1.7 billion 17.1%
Pension Funds $1.3 billion 13.2%

DCF model

Zoetis Inc. (ZTS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.